Supplementary Table S1 from Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells

crossref(2024)

引用 0|浏览6
暂无评分
摘要
Comparative analysis of tyrosine-phosphorylated peptides identified in vehicle or osimertinib treated CD34+ cells purified from three AML patients by LC-MS.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要